SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $35,517,000 | -17.8% | 364,160 | -21.8% | 0.01% | -17.6% |
| Q4 2014 | $43,222,000 | +35.5% | 465,800 | +0.4% | 0.02% | +30.8% |
| Q3 2014 | $31,902,000 | -38.0% | 463,824 | -5.6% | 0.01% | -35.0% |
| Q2 2014 | $51,466,000 | +62.2% | 491,086 | +28.4% | 0.02% | +53.8% |
| Q1 2014 | $31,727,000 | +1204.0% | 382,397 | +917.4% | 0.01% | +1200.0% |
| Q4 2013 | $2,433,000 | +70.5% | 37,587 | +67.0% | 0.00% | 0.0% |
| Q3 2013 | $1,427,000 | – | 22,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|